Breaking Down Astral Limited Financial Health: Key Insights for Investors

Breaking Down Astral Limited Financial Health: Key Insights for Investors

IN | Industrials | Construction | NSE

Astral Limited (ASTRAL.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Dive into Astral Limited's latest financial snapshot: revenue rose to ₹58,324 million in FY2025 (up 3.4% year-on-year) with the Plumbing segment contributing ₹42,000 million or 72% of sales, while cost of sales stood at ₹35,500 million (61% of revenue) and revenue missed estimates by 1.7%; profitability showed strain as net profit fell to ₹5,238 million (down 4.1%) and EPS slid to ₹19.50, EBITDA margin contracted to 13.58% in Q1 FY2026 from 15.50% a year earlier even as PBDIT rose to ₹987.20 million in March 2025 and Q2 FY2026 net profit improved to ₹1,499 million from ₹1,223 million; on the balance sheet long-term debt surged 106.4% to ₹898 million while debt-to-equity remained low at 0.04 and equity increased to ₹36,149 million, current assets climbed to ₹21,488 million (up 8.2%), operating cash flow for H1 FY2026 was ₹3,967 million, and growth levers include a manufacturing capacity of 549,126 MT per annum, exports to over 31 countries and plans for backward integration-keep reading to unpack what these numbers mean for investors.

Astral Limited (ASTRAL.NS) - Revenue Analysis

Astral Limited reported consolidated revenue for FY2025 of ₹58,324 million, up 3.4% from ₹56,414 million in FY2024. The increase reflects steady demand in core segments but marginally missed market expectations.

  • FY2025 revenue: ₹58,324 million (↑ 3.4% vs FY2024 ₹56,414 million)
  • Analyst consensus miss: 1.7% below estimates
  • Plumbing segment contribution: ₹42,000 million (72% of total revenue)
  • Cost of sales: ₹35,500 million (61% of total revenue)
  • Manufacturing capacity: 549,126 MT per annum
  • Export footprint: Sales to over 31 countries
Metric FY2025 FY2024 Notes
Total Revenue (₹ million) 58,324 56,414 3.4% YoY growth
Plumbing Segment Revenue (₹ million) 42,000 - 72% of FY2025 revenue
Cost of Sales (₹ million) 35,500 - Represents 61% of total revenue
Analyst Estimate Variance -1.7% - Slight underperformance vs consensus
Manufacturing Capacity (MT p.a.) 549,126 - Capacity across polymer & CPVC operations
Export Markets 31+ - Diversified international revenue streams

Key revenue drivers and dynamics:

  • Plumbing dominance: 72% revenue concentration in plumbing products underpins top-line stability but raises segment concentration risk.
  • Margin pressure: Cost of sales at 61% implies gross margin compression potential; monitoring input cost trends (resins, PVC, fuel) is critical.
  • Capacity utilization: 549,126 MT p.a. capacity provides scope for volume expansion and export scaling if utilization improves.
  • International diversification: Exports to 31+ countries reduce single-market dependence and support incremental growth.
  • Analyst miss: A 1.7% shortfall vs estimates signals modest execution or mix headwinds relative to street expectations.

For strategic context and company direction, see: Mission Statement, Vision, & Core Values (2026) of Astral Limited.

Astral Limited (ASTRAL.NS) - Profitability Metrics

Astral Limited's recent profitability profile shows mixed signals: steady operating strength in some periods alongside pressure on margins and bottom-line growth. The following section breaks down the key profit metrics and short-term movements investors should note.

  • Net profit (FY2025): ₹5,238 million - a decline of 4.1% from ₹5,461 million in FY2024.
  • Earnings per share (EPS) (FY2025): ₹19.50, down from ₹20.33 in FY2024.
  • EBITDA margin contracted to 13.58% in Q1 FY2026 from 15.50% in Q1 FY2025.
  • Operating profit (PBDIT) in March 2025: ₹987.20 million, up from ₹960.40 million in March 2024.
  • Profit before tax (PBT) in March 2025: ₹702.50 million, down from ₹733.70 million in March 2024.
  • Quarterly net profit (Q2 FY2026): ₹1,499 million, up from ₹1,223 million in Q2 FY2025.
Metric FY2024 FY2025 Q1 FY2025 Q1 FY2026 Q2 FY2025 Q2 FY2026 Mar-2024 Mar-2025
Net profit (₹ million) 5,461 5,238 - - 1,223 1,499 - -
EPS (₹) 20.33 19.50 - - - - - -
EBITDA margin (%) - - 15.50 13.58 - - - -
Operating profit / PBDIT (₹ million) - - - - - - 960.40 987.20
Profit before tax (₹ million) - - - - - - 733.70 702.50

Key interpretive points for investors:

  • Margin compression: The fall in EBITDA margin from 15.50% to 13.58% year-on-year in Q1 indicates pressure on core operating profitability, which can stem from higher raw-material costs, mix changes, or pricing pressures.
  • Mixed quarterly momentum: Q2 FY2026 net profit rose to ₹1,499 million (from ₹1,223 million), signaling that some quarters are delivering stronger earnings despite FY-level decline.
  • Operating resilience vs. tax/other items: PBDIT improved to ₹987.20 million in March 2025 versus ₹960.40 million a year earlier, but PBT and net profit trajectories show the impact of below-operating-line items and tax/exceptionals.
  • EPS contraction mirrors net profit drop: EPS fell to ₹19.50, consistent with the 4.1% decline in annual net profit, affecting per-share returns for investors.

For broader context on Astral Limited's business model, ownership and historical performance, see: Astral Limited: History, Ownership, Mission, How It Works & Makes Money

Astral Limited (ASTRAL.NS) - Debt vs. Equity Structure

Astral Limited's balance-sheet movements in FY2025 show a marked increase in long-term borrowings alongside steady equity growth, leaving leverage still low in absolute terms.

Metric FY2024 (₹ million) FY2025 (₹ million) Change
Long-term debt 435 898 +106.4%
Total liabilities 44,958 50,478 +12.3%
Equity 31,865 36,149 +13.4%
Debt-to-equity ratio 0.03 0.04 Up
Long-term debt repaid during year 133 -
  • Despite a 106.4% surge in long-term debt to ₹898 million, equity rose 13.4% to ₹36,149 million, cushioning leverage.
  • Total liabilities increased by ₹5,520 million to ₹50,478 million, reflecting higher operational or financing requirements.
  • Debt-to-equity at 0.04 in FY2025 remains low, signalling conservative financial leverage relative to peers.
  • The company repaid ₹133 million of long-term borrowings during the year, indicating active debt management.

Key implications for investors:

  • Low absolute debt-to-equity (0.04) suggests Astral maintains a healthy balance sheet with room to fund growth without risking solvency.
  • The sharp percentage rise in long-term debt warrants monitoring-understand the purpose (capex, acquisitions, working capital) and interest cost trajectory.
  • Equity growth of 13.4% supports capitalization and provides a buffer against liability expansion.

For further context on ownership and market positioning, see: Exploring Astral Limited Investor Profile: Who's Buying and Why?

Astral Limited (ASTRAL.NS) - Liquidity and Solvency

Astral Limited shows improving short-term liquidity and stable solvency markers driven by an 8.2% rise in current assets and modest growth in current liabilities, supported by robust operating cash generation.
  • Current assets: ₹21,488 million in FY2025 (up 8.2% from ₹19,856 million in FY2024).
  • Current liabilities: ₹11,433 million in FY2025 (up 2.0% from ₹11,212 million in FY2024).
  • Working capital: ₹10,055 million in FY2025 (Current assets - Current liabilities).
  • Current ratio (FY2025): 1.88 (21,488 / 11,433), versus 1.77 in FY2024.
Metric FY2024 FY2025 Change
Current Assets (₹ million) 19,856 21,488 +8.2%
Current Liabilities (₹ million) 11,212 11,433 +2.0%
Working Capital (₹ million) 8,644 10,055 +16.4%
Current Ratio 1.77 1.88 +0.11
Operating Cash Flow (H1 FY2026) (₹ million) - 3,967 H1 actual
Manufacturing Capacity (MT/annum) - 549,126 Installed capacity
Export Reach - Exports to over 31 countries Diversified markets
  • Operating cash flow strength: H1 FY2026 operating cash flow ~₹3,967 million supports near-term liquidity and capital expenditure needs.
  • Free cash flow: growth rate has been volatile historically, but Astral maintains a healthy operating cash flow to net income ratio (operating cash cushioning reported earnings-driven variability).
  • Capacity and diversification: 549,126 MT p.a. manufacturing capacity and exports to 31+ countries reduce single-market concentration risk.
Mission Statement, Vision, & Core Values (2026) of Astral Limited.

Astral Limited (ASTRAL.NS) - Valuation Analysis

Astral Limited's recent financials show modest pressure on earnings alongside continued balance-sheet strength. Key headline numbers drive the valuation narrative and investor considerations below.
Metric FY2024 FY2025
Earnings per Share (EPS) ₹20.33 ₹19.50
Debt-to-Equity Ratio 0.03 0.04
Long-term Debt Repaid ₹133 million repaid during FY2025
Manufacturing Capacity 549,126 MT per annum
  • EPS decline: FY2025 EPS fell to ₹19.50 from ₹20.33 in FY2024 - a ~4.1% decrease, which compresses earnings-based valuation multiples unless offset by margin recovery or revenue growth.
  • Market performance: the stock has underperformed broader market indices, which can widen its relative valuation discount and raise questions about growth visibility or sentiment.
  • Leverage profile: debt-to-equity rose slightly to 0.04 from 0.03, but remains very low, supporting a conservative capital-structure view.
  • Debt reduction: repayment of ₹133 million in long-term debt during the year reduces interest and refinancing risk and enhances net-debt-adjusted valuations.
  • Capacity and scale: 549,126 MT p.a. manufacturing capacity underpins future revenue potential and operating leverage if utilization improves.
  • Valuation implications: low leverage preserves upside to equity multiples (P/E, EV/EBITDA) if growth resumes; however, the EPS dip and stock underperformance argue for careful scrutiny of near-term profit drivers and margin sustainability.
  • Investor focus areas: revenue growth trajectory, margin recovery, utilization of the 549,126 MT capacity, and any further debt movements or capital allocation (dividends, buybacks, M&A).
Exploring Astral Limited Investor Profile: Who's Buying and Why?

Astral Limited (ASTRAL.NS) - Risk Factors

Astral Limited exhibits several financial and operational risk signals investors should weigh:
  • Revenue underperformance: Revenue missed analyst estimates by 1.7%, indicating slightly weaker top-line momentum versus expectations.
  • Margin compression: EBITDA margin contracted to 13.58% in Q1 FY2026 from 15.50% in Q1 FY2025, reflecting margin pressure from cost inflation or product mix shifts.
  • Profitability volatility: While operating profit (PBDIT) rose to ₹987.20 million in March 2025 from ₹960.40 million in March 2024, profit before tax fell to ₹702.50 million in March 2025 from ₹733.70 million in March 2024-signaling rising non-operating expenses, interest, or tax impacts.
  • Quarterly earnings trend: Net profit improved to ₹1,499 million in Q2 FY2026 from ₹1,223 million in Q2 FY2025, showing episodic strength but not eliminating underlying margin risks.
  • Capacity and utilization risk: The company reports manufacturing capacity of 549,126 MT per annum; underutilization or demand softness could amplify fixed-cost leverage and depress margins.
  • Execution and market risk: A small revenue miss and margin contraction increase sensitivity to raw material price swings, competitive pricing actions, and project execution delays.
Metric Period/Value
Revenue vs. Estimates Missed by 1.7%
EBITDA Margin Q1 FY2026: 13.58% | Q1 FY2025: 15.50%
Operating Profit (PBDIT) ₹987.20 million (Mar 2025) | ₹960.40 million (Mar 2024)
Profit Before Tax ₹702.50 million (Mar 2025) | ₹733.70 million (Mar 2024)
Net Profit (Quarter) ₹1,499 million (Q2 FY2026) | ₹1,223 million (Q2 FY2025)
Manufacturing Capacity 549,126 MT per annum
  • Balance-sheet and cash-flow sensitivity: Declines in PBT alongside rising operating profit suggest variability in non-operating items-monitor interest burden, working capital changes, and one-off items.
  • Investor implications: Given the mixed signals-quarterly net profit growth but margin erosion and a revenue miss-position sizing should account for execution risk and potential short-term earnings volatility.
Exploring Astral Limited Investor Profile: Who's Buying and Why?

Astral Limited (ASTRAL.NS) - Growth Opportunities

Astral Limited is positioning for structural growth by strengthening control over its raw-material supply, expanding manufacturing reach and leveraging export markets. The firm's strategic move toward backward integration to manufacture CPVC resin aims to improve margins, reduce raw-material volatility and secure supply for its plumbing and adhesive product lines.
  • Backward integration: plan to manufacture CPVC resin to reduce dependence on external suppliers and lower input cost volatility.
  • Installed manufacturing capacity: 549,126 MT per annum, supporting scale across plumbing, adhesives and specialty polymers.
  • Export footprint: products sold in over 31 countries, providing geographic diversification and foreign-currency revenue potential.
The following table summarizes recent financial outcomes that illustrate where growth is translating into profits and where pressures remain:
Metric Q2 FY2025 Q2 FY2026 March 2024 (FY end) March 2025 (FY end)
Net profit (₹ million) 1,223 (Q2 FY2025) 1,499 (Q2 FY2026) - -
Operating profit / PBDIT (₹ million) - - 960.40 (Mar 2024) 987.20 (Mar 2025)
Profit before tax (₹ million) - - 733.70 (Mar 2024) 702.50 (Mar 2025)
Manufacturing capacity (MT pa) 549,126
Export markets Exports to 31+ countries
Key catalysts and operational priorities for scaling value:
  • CPVC resin manufacturing - expected to shorten lead times and improve gross margins once commercialized.
  • Utilization of 549,126 MT capacity - incremental volume capture in domestic renovation and construction cycles.
  • Export expansion - incremental revenue and margin diversification from 31+ country presence.
  • Margin management - continued focus on PBDIT improvement (PBDIT rose from ₹960.40m to ₹987.20m year-on-year at fiscal year end).
Short-term financial dynamics to monitor:
  • Net profit momentum - Q2 FY2026 net profit rose to ₹1,499m from ₹1,223m in Q2 FY2025, indicating operational leverage in recent quarters.
  • PBT headwinds - profit before tax fell to ₹702.50m in March 2025 from ₹733.70m in March 2024, underscoring tax, interest or non-operating pressures that need addressing.
Further context on Astral's strategic positioning and corporate background can be found here: Astral Limited: History, Ownership, Mission, How It Works & Makes Money

DCF model

Astral Limited (ASTRAL.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.